english.prescrire.org > Spotlight > Archives : 2022 > The Prescrire Awards for 2021: two "Pilule d'Or" Awards, and 5 drugs on the "Honours List". Details in the March issue of Prescrire International

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2022 : 1 | 30 | 60

The Prescrire Awards for 2021: two "Pilule d'Or" Awards, and 5 drugs on the "Honours List". Details in the March issue of Prescrire International

ThePrescrire Awards independent French medical journal Prescrire conferred two "Pilule d'Or" ("Golden Pill") Awards for 2021; 5 drugs made the "Honours List", and 2 drugs were deemed "Noteworthy". Details for the Drug and Information Awards, published in the March issue of Prescrire International, are available HERE.

Each month, the not-for-profit French journal Prescrire publishes systematic, independent analyses of the available evidence regarding new drugs, newly authorised indications for drugs already on the market, and new forms or new dose strengths of existing drugs.

The goal is to select, amidst the multitude of new products, those which deserve to be added to the list of useful therapeutic options, or ought to be used in place of other drugs.

The annual Prescrire Awards recognise drugs, drug packaging and drug information singled out for notice by Prescrire's editorial staff. Prescrire's editors announced the Prescrire Awards for 2021 in Paris on 25 January 2022.

 "Pilule d'Or" Awards 

The "Pilule d'Or" ("Golden Pill") is granted to drugs that represent a major therapeutic advance in a field in which no treatment was previously available.

  • Comirnaty° (tozinameran), BioNTech/Pfizer

  • Spikevax° (elasomeran), Moderna
     

Honours List

Drugs included on the Honours List constitute a clear advance for some patients compared with existing therapeutic options, albeit with limitations.

  • Baqsimi° (nasal glucagon), Lilly 
     
  • Covid-19 Vaccine Janssen° (covid-19 vaccine Ad26.CoV2-S), Janssen Cilag
     
  • Givlaari° (givosiran), Alnylam
     
  • Mabthera° or other brands (rituximab), Roche
     
  • Vaxzevria° (covid-19 vaccine ChAdOx1-S), AstraZeneca
     

Noteworthy

Drugs that are deemed "Noteworthy" provide a modest improvement in patient care.

  • Jorveza° (budesonide orodispersible tablets), Dr. Falk Pharma
     
  • Kaftrio° (ivacaftor + tezacaftor + elexacaftor), Vertex Pharmaceuticals

For details, see:
Le Palmarès Prescrire
> The Prescrire Awards for 2021
 

©Prescrire 1 March 2022

Source: "The Prescrire Awards" Prescrire International 2022; 31 (235): 79-82. Free.

Enjoy full access to Prescrire International, and support independent information
Share
Share on Facebook Share on Twitter


For more information:

"The Prescrire Awards for 2021"
(February 2022)
Free

 
Read more:

All the subjects in
Prescrire's Spotlight
Free >